These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35014619)

  • 1. Newborn Screening and Clinical Profile of Children With Sickle Cell Disease in a Tribal Area of Gujarat.
    Dave K; Desai S; Italia Y; Mukherjee MB; Mehta P; Desai G
    Indian Pediatr; 2022 Mar; 59(3):230-233. PubMed ID: 35014619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of a newborn screening and follow-up programme for sickle cell disease among South Gujarat (India) tribal populations.
    Italia Y; Krishnamurti L; Mehta V; Raicha B; Italia K; Mehta P; Ghosh K; Colah R
    J Med Screen; 2015 Mar; 22(1):1-7. PubMed ID: 25341880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sickle cell disease and pregnancy outcomes: a study of the community-based hospital in a tribal block of Gujarat, India.
    Desai G; Anand A; Shah P; Shah S; Dave K; Bhatt H; Desai S; Modi D
    J Health Popul Nutr; 2017 Jan; 36(1):3. PubMed ID: 28109314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extremely high birth prevalence of sickle cell disease in rural Tanzania.
    Eastburg L; Peckham A; Kawira E; Chirangi B; Adler D; Akungo BD; Smart LR; Ambrose EE
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28620. PubMed ID: 32803850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India.
    Upadhye DS; Jain DL; Trivedi YL; Nadkarni AH; Ghosh K; Colah RB
    PLoS One; 2016; 11(1):e0147081. PubMed ID: 26785407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn Screening for Sickle Cell Disease Among Tribal Populations in the States of Gujarat and Madhya Pradesh in India: Evaluation and Outcome Over 6 Years.
    Thaker P; Colah RB; Patel J; Raicha B; Mistry A; Mehta V; Italia Y; Desai S; Dave K; Shanmugam R; Ghosh K; Mukherjee MB
    Front Med (Lausanne); 2021; 8():731884. PubMed ID: 35242766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation.
    Núñez-Jurado D; Payán-Pernía S; Álvarez-Ríos AI; Jiménez-Jambrina M; Concepcion Pérez-De-Soto I; José Palma-Vallellano A; Zapata-Bautista R; Carlos Hernández-Castellet J; Paz Garrastazul-Sánchez M; Arqueros-Martínez V; Urbano-Ramos MDM; Abdelkader-Maanan M; Raúl García-Lozano J; Delgado-Pecellín C
    Am J Perinatol; 2024 May; 41(S 01):e893-e900. PubMed ID: 36580977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell disease in tribal populations in India.
    Colah RB; Mukherjee MB; Martin S; Ghosh K
    Indian J Med Res; 2015 May; 141(5):509-15. PubMed ID: 26139766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal screening for sickle cell disease in France.
    Bardakdjian-Michau J; Bahuau M; Hurtrel D; Godart C; Riou J; Mathis M; Goossens M; Badens C; Ducrocq R; Elion J; Perini JM
    J Clin Pathol; 2009 Jan; 62(1):31-3. PubMed ID: 19103855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal screening of sickle cell anemia: a preliminary report.
    Panigrahi S; Patra PK; Khodiar PK
    Indian J Pediatr; 2012 Jun; 79(6):747-50. PubMed ID: 22278214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neonatal screening of hemoglobinopathies and G6PD deficiency in Catalonia (Spain). Molecular study of sickle cell disease associated with alpha thalassemia and G6PD deficiency].
    Mañú Pereira Mdel M; Cabot A; Martínez González A; Sitjà Navarro E; Cararach V; Sabrià J; Boixaderas J; Teixidor R; Bosch A; López Vílchez MA; Martín Ibáñez I; Carrión T; Plaja P; Sánchez M; Vives Corrons JL
    Med Clin (Barc); 2007 Jun; 129(5):161-4. PubMed ID: 17669331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia.
    Paulukonis ST; Snyder A; Smeltzer MP; Sutaria AN; Hurden I; Latta K; Chennuri S; Vichinsky E; Reeves SL
    J Pediatr Hematol Oncol; 2023 May; 45(4):174-180. PubMed ID: 37083273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT
    Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.
    Mano RM; Kuona P; Misihairabgwi JM
    BMC Pediatr; 2024 May; 24(1):323. PubMed ID: 38730340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Screening.
    Burnham-Marusich AR; Ezeanolue CO; Obiefune MC; Yang W; Osuji A; Ogidi AG; Hunt AT; Patel D; Ezeanolue EE
    Public Health Genomics; 2016; 19(5):298-306. PubMed ID: 27614873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
    Nkya S; Mtei L; Soka D; Mdai V; Mwakale PB; Mrosso P; Mchoropa I; Rwezaula S; Azayo M; Ulenga N; Ngido M; Cox SE; D'Mello BS; Masanja H; Kabadi GS; Mbuya F; Mmbando B; Daniel Y; Streetly A; Killewo J; Tluway F; Lyimo M; Makani J
    Int Health; 2019 Nov; 11(6):589-595. PubMed ID: 31145786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease.
    Moat SJ; Rees D; King L; Ifederu A; Harvey K; Hall K; Lloyd G; Morrell C; Hillier S
    Clin Chem; 2014 Feb; 60(2):373-80. PubMed ID: 24158758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
    Tubman VN; Marshall R; Jallah W; Guo D; Ma C; Ohene-Frempong K; London WB; Heeney MM
    Pediatr Blood Cancer; 2016 Apr; 63(4):671-6. PubMed ID: 26739520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.